Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip
NCT ID: NCT01133938
Last Updated: 2010-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
79 participants
OBSERVATIONAL
2009-01-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does a 6-week Duration of Hip Spica Immobilization Provide Comparable Clinical and Radiological Outcomes to 12 Weeks in Children Undergoing Open Reduction and Pelvic Osteotomy for Developmental Dysplasia of the Hip (DDH)?
NCT07289256
Supracondylar Femur Fracture After DDH
NCT06142305
Risk Factors for Cut-out After Internal Fixation of Trochanteric Fractures in Elderly Subjects.
NCT03975868
Follow-Up of the Prevision® Hip Stem
NCT04833634
Early Surgical Fixation of Low-Velocity Hip Fractures in Patients With Direct Oral Anticoagulation
NCT05070169
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Closed reduction < 12 months of age
No interventions assigned to this group
Open reduction < 12 months of age
No interventions assigned to this group
Open reduction with concomitant osteotomies > 12 months fo age
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* neuromuscular disease
* previous open reduction at another medical institution
1 Month
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Orthopedic Hospital Vienna Speising
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orthopedic Hospital Vienna Speising
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopedic Hospital Vienna Speising
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OR-27052010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.